Investigation of the Pharmacokinetic Profile of CBD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The goal of the current study is to evaluate the bioavaibiltiy of CBD in normal healthy Individuals. This is an open cross-over design study in healthy individuals to assess the safety and pharmacokinetic (PK) effects of cannabidiol.
Epistemonikos ID: 932c3b970a514ab493758a081a53fca5fdfa52c6
First added on: May 09, 2024